Analysis of Vital Farms Inc (VITL)
Vital Farms Inc (VITL) has shown a strong uptrend in the past few days, with the price closing at $41.38 on May 31st. The Relative Strength Index (RSI) is indicating overbought conditions at 76.32, suggesting a potential reversal or correction in the near future.
The Moving Average Convergence Divergence (MACD) indicator is positive at 3.66, with the MACD line above the signal line, indicating bullish momentum. The MACD histogram is also positive at 0.04, supporting the bullish trend.
The Simple Moving Average (SMA) is at $35.09, which is below the closing price, indicating a bullish trend. The Exponential Moving Average (EMA) and Weighted Moving Average (WMA) are also below the closing price, further supporting the bullish outlook.
Overall, based on the technical indicators, Vital Farms Inc seems to be in a strong bullish trend, but traders should be cautious of a potential correction due to the overbought RSI levels.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has a beta of 1.264, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The 52-week range is between $164.08 and $199.62.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The market capitalization is $2.92 trillion.
Lastly, dividends and splits information indicates a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company has a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The last split date was on August 31, 2020, with a 4-for-1 split. The next dividend date is on May 16, 2024, with an ex-dividend date on May 10, 2024.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, indicating overall profitability growth.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. The company's interest expenses have been relatively stable, suggesting effective debt management.
9. Overall, the financial performance of the company seems to be positive, with increasing revenues and profitability over the years.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated, with the highest value in 2019 at $162.8 billion and the lowest in 2023 at $135.4 billion.
3. Non-current assets have shown an increasing trend, reaching $217.4 billion in 2022 and then slightly decreasing to $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has also been increasing, with the highest value in 2023 at $62.1 billion.
6. The company has been relying more on non-current liabilities compared to current liabilities in recent years.
7. The company has been investing more in non-current assets like investments and advances, machinery, furniture, and equipment.
8. The accumulated depreciation has been increasing, indicating the aging of the company's assets.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This demonstrates growth compared to the EPS of $5.67 from the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are forecasting moderate growth in both quarterly and annual sales for the company, with a more significant increase expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase further to 9.7% in the next year.
5. Past 5 Years: The company has shown a strong growth rate of 20.1% on average over the past 5 years.
6. Next 5 Years: Looking ahead, analysts project a growth rate of 9.7% per year on average for the next 5 years.
Overall, the company is expected to maintain a solid growth trajectory, with a slight increase in growth rates in the upcoming periods compared to the current ones.
Price target
The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security paper, with a median forecast above the current price. However, there is a wide range of predictions, from $164 to $275, indicating some uncertainty in the market.MACD of VITL